Workflow
180 Life Sciences (ATNF)
icon
Search documents
180 Life Sciences (ATNF) - 2024 Q3 - Quarterly Report
2024-11-14 21:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38105 180 LIFE SCIENCES CORP (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------- ...
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
GlobeNewswire News Room· 2024-09-12 20:15
PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez, already a director of the Company, will play a key role in driving the financial strategy of the Company as it continues to grow and innovate in the pharma and biotechnology sectors. "We are excited to have Omar stepping onto our executive team," said Mr. Blair Jordan, CEO o ...
180 Life Sciences (ATNF) - 2024 Q2 - Quarterly Report
2024-08-12 21:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 Delaware 90-1890354 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Market LLC (The NASDAQ Capital Market) Warrants to purchase Common Stock ATNFW The NASDAQ Stock Market LLC (The NASDAQ Capital Market) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT ...
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
GlobeNewswire News Room· 2024-07-30 12:00
PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced topline results from a clinical pharmacology study (the “Study”), that evaluated the uptake of cannabidiol (CBD) in a solid formulation which can be delivered as a pill orally. The clinical trial in humans, performed with Prof. Avi Domb of the Hebrew University, School of Pharmacy, and with Prof. Elyad Davidso ...
180 Life Sciences (ATNF) - 2024 Q1 - Quarterly Report
2024-05-15 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38105 180 LIFE SCIENCES CORP (Exact name of registrant as specified in its charter) | --- | --- | |------------------------------ ...
180 Life Sciences (ATNF) - 2023 Q4 - Annual Report
2024-03-23 01:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: __________ to __________ Commission File Number: 001-38105 180 LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) | --- | --- | |--------- ...
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Newsfilter· 2024-03-14 12:30
PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company received a letter on March 13, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Requirement"). As indicated in the letter, Nasdaq determined that for 10 consecutive ...
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
Newsfilter· 2024-02-26 12:00
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-19 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective on February 28, 2024 at 12:01 p.m. Eastern Time (the "Effective Time"), with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted, at market o ...
180 Life Sciences (ATNF) - 2023 Q3 - Quarterly Report
2023-11-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38105 180 LIFE SCIENCES CORP (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------- ...
180 Life Sciences (ATNF) - 2023 Q2 - Quarterly Report
2023-08-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 Delaware 90-1890354 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Market LLC (The NASDAQ Capital Market) Warrants to purchase Common Stock ATNFW The NASDAQ Stock Market LLC (The NASDAQ Capital Market) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT ...